Company intelligence / Profile preview
AMKS Time Release
- Ownership
- Private
- Development stage
- Other
01
Overview
AMKS Time Release is a biotechnology company focused on developing advanced drug delivery systems designed to optimize the therapeutic profile of existing medications. The company's core technology centers on a proprietary time-release mechanism that allows for controlled, sustained delivery of active pharmaceutical ingredients over extended periods. By improving the pharmacokinetic properties of drugs, AMKS aims to enhance patient compliance, reduce side effects, and improve overall clinical outcomes. Their current research and development efforts are primarily directed toward pain management and chronic disease treatments where consistent dosing is critical.
- Therapeutic areas
- NeurologyOther
- Modalities
- Small moleculeDrug delivery system
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on AMKS Time Release.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AMKS Time Release.